Stay updated on Adjunctive Troriluzule in OCD Clinical Trial

Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.5%
    Check dated 2025-09-14T00:26:49.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.5%
    Check dated 2025-09-06T21:14:35.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, while removing specific location terms and listed location countries. This indicates a shift towards a more streamlined presentation of location information.
    Difference
    72%
    Check dated 2025-08-30T15:43:41.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new completion status and a future date of August 19, 2025, while removing a previous status indicating that it was not actively recruiting and a date of January 14, 2025.
    Difference
    1%
    Check dated 2025-08-23T14:15:25.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T12:30:02.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T07:56:05.000Z thumbnail image

Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.